{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:29:37Z","timestamp":1774672177733,"version":"3.50.1"},"reference-count":16,"publisher":"BMJ","issue":"6595","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1987,8,15]]},"DOI":"10.1136\/bmj.295.6595.421","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T19:19:55Z","timestamp":1238699995000},"page":"421-424","source":"Crossref","is-referenced-by-count":63,"title":["Human immunodeficiency virus and drug misuse: the Edinburgh experience."],"prefix":"10.1136","volume":"295","author":[{"given":"R P","family":"Brettle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Bisset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S J","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Inglis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"641","volume":"i:","author":"I Anonymous. Aids in the UK","year":"1987","unstructured":"I Anonymous. Aids in the UK. Lancet 1987;i:641.","journal-title":"Lancet"},{"key":"ref_2","first-page":"\"10","article-title":"Acquired immune deficiencv syndrome (AIDS)-United States","volume":"1986","author":"Anonymous","year":"1987","unstructured":"Anonymous. Acquired immune deficiencv syndrome (AIDS)-United States. Glasgow: Communicable Diseases (Scotland) Unit, 1986:10-1. (86\/36.) 3 Anonvmous. Human immunodeficiency virus (HTLV3\/LAV) antibody reports England, Wales and Northern Ireland: weeks 84\/50-87\/04 and acquired immune deficiency syndrome: United Kingdom: January 1987. Communicable disease report. London: PHLS Communicable Disease Surveillance Centre, 1987:3-4. (87\/05.) 4 Anonymous. Human immunodeficiency virus (HIV) infection. Communicable diseases Scotland weekly report. Glasgow: Communicable Diseases (Scotland) Unit, 1987:10-1. (87\/04.) 5 Peutherer JF, Edmond E, Simmonds P, Dickson JD, Bath GE. HTLV-III antibody in Edinburgh drug addicts. Lancet 1985;ii: 1129-30.","journal-title":"Glasgow: Communicable Diseases (Scotland) Unit; 3 Anonvmous. Human immunodeficiency virus (HTLV3\/LAV) antibody reports England, Wales and Northern Ireland: weeks 84\/50-87\/04 and acquired immune deficiency syndrome"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bmj.292.6519.527","article-title":"An epidemic of AIDS-related virus (HTLV-III\/ LAV) infection among intravenous drug abusers in a Scottish general practice","volume":"292","author":"Robertson, JR, Bucknall; ABV, Welsby; P.D.","year":"1986","unstructured":"Robertson JR, Bucknall ABV, Welsby PD, et al. An epidemic of AIDS-related virus (HTLV-III\/ LAV) infection among intravenous drug abusers in a Scottish general practice. Br Med j 1986;292:527-30.","journal-title":"Br Med j"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(86)91367-X","article-title":"HTLV-III antibodies in an Edinburgh clinic","volume":"i:","author":"Brettle, R.P.; Davidson, J.; Davidson, S.","year":"1986","unstructured":"Brettle RP, Davidson J, Davidson S, et al. HTLV-III antibodies in an Edinburgh clinic. Lancet 1986;i: 1099.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(86)91571-0","article-title":"Regional variations in HIV antibody seropositivitv in British intravenous drug users","volume":"i:","author":"Robertson, JR, Bucknall; ABV, Wiggins; P.","year":"1986","unstructured":"Robertson JR, Bucknall ABV, Wiggins P. Regional variations in HIV antibody seropositivitv in British intravenous drug users. Lancet 1986;i: 1435-6.","journal-title":"Lancet"},{"key":"ref_6","first-page":"1671","article-title":"Epidemic of AIDS related virus infection among intravenous drug abusers","volume":"292","author":"Brettle, R.P.","year":"1986","unstructured":"Brettle RP. Epidemic of AIDS related virus infection among intravenous drug abusers. Br Med]7 1986;292: 1671."},{"key":"ref_7","first-page":"721","article-title":"Centers for Disease Control. Recommendations for assisting in the prevention of perinatal transmission of HTLV-III\/LAV and AIDS","volume":"34","year":"1985","unstructured":"Centers for Disease Control. Recommendations for assisting in the prevention of perinatal transmission of HTLV-III\/LAV and AIDS. MMWR 1985;34:721-32.","journal-title":"MMWR"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jama.1985.03350270061022","article-title":"Mothers of infants with the acquired immunodeficiencv syndrome","volume":"253","author":"Scott, G.B.; Fischl, M.A.; Klimas, N.","year":"1985","unstructured":"Scott GB, Fischl MA, Klimas N, et al. Mothers of infants with the acquired immunodeficiencv syndrome. JAMA, 1985;253:363-6.","journal-title":"JAMA"},{"key":"ref_9","first-page":"446","article-title":"HTLV-III antibodv in drug abusers in the west of Scotland: the Edinburgh connection","volume":"i:","author":"Follet, E.A.I.; McIntyre, A.; O'Donnell, B.; Clements, G.B.; Desselberger, U.","year":"1986","unstructured":"Follet EAI, McIntyre A, O'Donnell B, Clements GB, Desselberger U. HTLV-III antibodv in drug abusers in the west of Scotland: the Edinburgh connection. Lancet 1986;i:446-7.","journal-title":"Lancet"},{"key":"ref_10","first-page":"155","article-title":"Prevalence of anti-HTLV-IlI in UK risk groups 1984\/85","volume":"i:","author":"Jesson, W.J.; Thorp, R.W.; Mortimer, P.P.; Oates, J.K.","year":"1986","unstructured":"Jesson WJ, Thorp RW, Mortimer PP, Oates JK. Prevalence of anti-HTLV-IlI in UK risk groups 1984\/85. Lancet 1986;i: 155.","journal-title":"Lancet"},{"key":"ref_11","first-page":"467","article-title":"Prevalence of antibody to lymphadenopthy associated virus among drug detoxification patients in New York","volume":"313","author":"Spira, T.J.; Des Jarlais, D.C.; Marmor, M.","year":"1984","unstructured":"Spira TJ, Des Jarlais DC, Marmor M, et al. Prevalence of antibody to lymphadenopthy associated virus among drug detoxification patients in New York. N EnglJ Med 1984;313:467-8.","journal-title":"N EnglJ Med"},{"key":"ref_12","first-page":"446","article-title":"The prevalence of HTLV- III\/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl3'","volume":"314","author":"Levy, N.; Carlson, JR, Hinrichs; S, Lerche; N, Schenker; M, Gardner; M.B.","year":"1986","unstructured":"Levy N, Carlson JR, Hinrichs S, Lerche N, Schenker M, Gardner MB. The prevalence of HTLV- III\/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl3' Med 1986;314:446.","journal-title":"Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(86)91815-5","article-title":"Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military base","volume":"i:","author":"Franceschi, S.; Tirelli, U.; Vaccher, E.","year":"1986","unstructured":"Franceschi S, Tirelli U, Vaccher E, et al. Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military base. Lancet 1986;i:804.","journal-title":"Lancet"},{"key":"ref_14","first-page":"284","article-title":"Centers for Disease Control. Human T-lymphotropic virus tvpe III\/lymphadenopathv-associated virus antibody testing at alternative sites","volume":"35","year":"1986","unstructured":"Centers for Disease Control. Human T-lymphotropic virus tvpe III\/lymphadenopathv-associated virus antibody testing at alternative sites. MMWR 1986;35:284-7.","journal-title":"MMWR"},{"key":"ref_15","article-title":"Accepted IS","year":"1987","unstructured":"(Accepted IS April 1987)"},{"key":"ref_16","article-title":"The medical curriculum is becoming more and more crowded as everybody wants to teach the essential facts of his specialty. A course covering all possible options would have to be several years longer than at present, and teachers therefore need to be selective and deal with the principles and approaches entailed in different subjects rather than with straight facts. If the division of time in the From How To Do It: 2, a new collection ofuseful advice","volume-title":"this is a companion volume to the popular How","author":"To Do It: 1, also published by the BM7.","year":"1987","unstructured":"The medical curriculum is becoming more and more crowded as everybody wants to teach the essential facts of his specialty. A course covering all possible options would have to be several years longer than at present, and teachers therefore need to be selective and deal with the principles and approaches entailed in different subjects rather than with straight facts. If the division of time in the From How To Do It: 2, a new collection ofuseful advice on topics that doctors need to know about but won't find in the medical textbooks. To be published in October 1987, this is a companion volume to the popular How To Do It: 1, also published by the BM7."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.295.6595.421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:39:39Z","timestamp":1601073579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.295.6595.421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,8,15]]},"references-count":16,"journal-issue":{"issue":"6595","published-print":{"date-parts":[[1987,8,15]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.295.6595.421","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,8,15]]}}}